Physicians’ preferences for bone metastases treatments in France, Germany and the United Kingdom

Purpose The aim of this study was to assess patients’ preferences for efficacy, safety, and mode of administration in relation to available bone-targeted agents (BTA) for the prevention of skeletal-related events (SREs) associated with bone metastases in Europe.